February 2001

 

Beechwood Surgery

Audit: Management of patients with a diagnosis of Atrial Fibrillation

Standard

 

Criteria

 

A computer search revealed that 136 patients of a Practice population of ­ had a recorded diagnosis of atrial fibrillation

Of these 25% i.e. 30 were randomly selected for the audit in the age group of 56+

A separate audit of those under 55 years was undertaken i.e. 10 patients

Of the 30 > 55yrs the following was found

Male ® 11 Age range 58 – 83yrs

Female ® 19 Age range 59 – 98yrs

Medication relevant to Audit

Those currently taking:

Of those taking neither

resolved

New episode 10/2000

Further GP review needed as per computer

screen

inappropriate

Cardioversion

Flicanide then reverts back to sinus rhythm

Pacemakers

heart block - AF under control

& AF

Other than from the above, no other reference regarding cardioversion

was found in the remaining audited patients

It was noted during the audit that 21 of out 30 patients had had some

referral/review with a cardiologist at some time – not necessarily in

direct relation to atrial fibrillation

 

Associated conditions identified for some patients

Congestive cardiac failure

Left ventricular failure

Hypertension

C.A.B.G

Myocardial infarction

CVA

Valvular disease

 

Of the 10 patients < 55yrs of age the following was found

Medication relevant to audit

Those currently taking: Warfarin 2

Aspirin 3

Neither 5

Of those taking neither:

palpitations

trauma – reviewed by a cardiologist

cardiologist and discharged

referral

 

Cardioversion

Declined other intervention

c/o cardiologist

 

No other reference to cardioversion noted in remaining patients records

 

Cardiology review

It could be seen during the audit that 8 out of 10 patients had had a cardiology review

 

 

 

 

 

Conclusions

 

 

 

It us difficult to ascertain from records whether or not the option is discussed, if appropriate, with the patients

 

 

 

 

re: anticoagulation therapy, but on current records it is not possible to measure the rate of offering cardioversion to those patients with recent onset of atrial fibrillation within two months of diagnosis